Research To Practice | Oncology Videos

Featuring perspectives from Drs Antonio González-Martín, Joyce Liu and Kathleen Moore, including the following topics: Introduction (0:00) Clinical Management of Advanced Ovarian Cancer (2:23) Novel Treatments and Strategies Under Investigation (46:04) CME information and select publications

Featuring perspectives from Drs Andrew Armstrong, Alan Bryce and Alicia Morgans, including the following topics: Introduction (0:00) Case: A man in his early 70s with DIPSS low- to intermediate-risk post-essential thrombocythemia myelofibrosis (MF) — Warren S Brenner, MD (5:29) Case: A woman in her late 60s with primary MF who experiences disease progression after 3 years of ruxolitinib — Jeanne Palmer, MD (17:19) Case: A woman in her late 60s with disease progression after multiple regimens for post-polycythemia vera MF — Neil Morganstein, MD (30:51) A woman in her late 70s with post-PV MF with a JAK2 V617F mutation and transfusion dependence — Bhavana (Tina) Bhatnagar, DO (39:33) Case: A man in his mid 60s with primary MF with a JAK2 mutation and recurrent herpes zoster reactivation on ruxolitinib — Niyati A Nathwani, MD (50:23) Case: A man in his early 70s with prefibrotic primary MF with a JAK2 mutation and ruxolitinib-associated HPV reactivation — Susannah Friemel, MD (53:36) Case: A man in his early 20s with myeloproliferative neoplasm with a JAK2 V617F mutation and thrombocytosis — Rajni Sinha, MD, MRCP (57:16) CME information and select publications

Featuring perspectives from Prof Harry Yoon, including the following topics: Introduction (0:00) Case: A woman in her late 30s with Stage IIIA HER2-negative adenocarcinoma of the gastric antrum (pMMR, PD-L1 CPS Case: A man in his mid 70s with metastatic esophageal adenocarcinoma (PD-L1 CPS 5) — Gurveen Kaur, MD (16:01) Case: A man in his mid 70s with HER2-negative gastroesophageal junction adenocarcinoma with multiple brain metastases (microsatellite stable, PD-L1 CPS 10) — Neil Morganstein, MD (29:00) Case: A man in his early 60s with HER2-positive esophageal adenocarcinoma (PD-L1 70%) — Kapisthalam (KS) Kumar, MD (42:19) Case: A man in his early 60s with HER2-positive metastatic gastric cancer — Dr Morganstein (49:37) CME information and select publications

Featuring perspectives from Drs Courtney DiNardo, Michael Savona and Eunice Wang, including the following topics: Introduction (0:00) Selection of therapy for older and younger patients with acute myeloid leukemia (AML) (2:05) Therapy for patients with AML with targetable mutations (33:42) Current and future management of myelodysplastic syndromes (49:04) CME information and select publications

Featuring perspectives from Dr Kristen Ciombor and Ms Jessica Mitchell, including the following topics: Introduction (0:00) Management of localized disease (10:56) Management of HER2-negative metastatic disease (34:36) Management of HER2-positive metastatic disease (57:08) NCPD information and select publications

Featuring perspectives from Dr John Mascarenhas, including the following topics: Introduction (0:00) Case: A man in his mid 60s with post-PV myelofibrosis (MF) and ASXL1 and SRSF2 mutations — Jeanne Palmer, MD (22:40) Case: A woman in her early 70s with high-risk primary MF and a CALR mutation (28:34) Case: A woman in her mid 70s with primary MF with a JAK2 V617F mutation — Bhavana (Tina) Bhatnagar, DO (40:24) Case: A woman in her early 50s with secondary MF with a JAK2 mutation — G Richard Polkinghorn, MD (43:30) Case: A woman in her mid 80s with primary MF with an MPL mutation — Warren S Brenner, MD (47:01) Case: A woman in her mid 80s with JAK2 mutation-positive primary MF with ASXL1 and U2F2 mutations with severe anemia — Neil Morganstein, MD (53:01) Case: A woman in her mid 80s with MF with a JAK2 mutation and severe anemia — Paul Markowski, MD (56:44) CME information and select publications

Featuring perspectives from Ms Lesley Camille Ballance, Ms Amy Goodrich, Dr Lowell Hart and Dr Anthony Mato, including the following topics: Introduction (0:00) Overview of Chronic Lymphocytic Leukemia (5:47) Bruton Tyrosine Kinase Inhibitors (27:40) Venetoclax and Anti-CD20 Antibody Therapy (58:59) Future Strategies (1:15:51) NCPD information and select publications

Featuring perspectives from Ms Monica Averia, Dr Shilpa Gupta, Ms Brenda Martone and Dr Sumanta Kumar Pal, including the following topics: Introduction (0:00) Management of Localized Urothelial Bladder Cancer (UBC): Adjuvant Treatment, TAR-200 (6:47) Management of Metastatic UBC: Antibody-Drug Conjugates, Checkpoint Inhibitors (33:00) Management of UBC with an FGFR Mutation (57:37) Oncology/UBC 2032 and a Crystal Ball (1:19:52) NCPD information and select publications

Featuring perspectives from Ms Ilene Galinsky and Dr Eunice Wang, including the following topics: Introduction (0:00) Younger patients with acute myeloid leukemia (AML) (2:11) Older patients with AML (34:45) Treatment for myelodysplastic syndromes (49:57) NCPD information and select publications

Featuring perspectives from Dr Susan O'Brien, including the following topics: Introduction (0:00) Case: A woman in her mid 60s with relapsed Chronic Lymphocytic Leukemia (CLL) who experiences severe headaches on acalabrutinib — Bhavana (Tina) Bhatnagar, DO (12:57) Case: A man in his early 70s with IGHV-unmutated relapsed CLL — Gurveen Kaur, MD (24:43) Case: A man in his late 60s with chronic kidney disease and CLL who develops metastatic rectal cancer while receiving acalabrutinib — G Richard Polkinghorn, MD (31:11) Case: A woman in her mid 60s with relapsed CLL suspicious for Richter's transformation; Del(13q), TP53 and BTK resistance mutation — John N Allan, MD (35:18) Case: A woman in her mid 20s with CLL and transfusion-dependent autoimmune myelofibrosis — Amanda Blackmon, DO, MS (48:47) Journal Club with Susan O'Brien, MD (53:07) CME information and select publications